Evaluation of a Simple-Prep Controlled Embolic

Clinical trial NCT06453642 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06453642
Sponsor: Fluidx Medical Technology, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Embolization Vascular Tumor Renal Angiomyolipoma Renal Cell Carcinoma Bone Tumor Portal Vein Embolization

Start date: 2024-11-18
Primary completion: 2026-05-01
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.